<DOC>
	<DOCNO>NCT01264978</DOCNO>
	<brief_summary>The aim study are:1.To evaluate utility quadriceps RMNMS ( repetitive magnetic neuromuscular stimulation ) evolution COPD patient hospital admission acute exacerbation.2 To evaluate time schedule recovery change muscle parameter , exercise capacity quality life acute exacerbation . 3.To test use new method training acute clinical situation . Patients : COPD patient admit Hospital acute exacerbation . Group 1 : RMNMS Treatment .Group 2 : sham RMNMS treatment . Randomized assignment minimization method . PROTOCOL Training Group : 10 day discharge 8 week , 2-3 days/week . Measures : Spirometry , Plethysmography , Diffusion Test . Main outcome : Exercise test ( Six minute walk distance ) . Muscle function : MVC . Health related quality life .</brief_summary>
	<brief_title>Evaluation Utility Quadriceps Magnetic Stimulation COPD ( Chronic Obstructive Pulmonary Disease ) Patients After Hospital Exacerbation</brief_title>
	<detailed_description>Study type Randomized control clinical trial aim evaluate eight-week protocol repetitive magnetic stimulation ( RMNMS ) quadriceps muscle COPD patient inhospital treated exacerbation . The outcome assess parameter relate quadriceps muscle function , exercise capacity ( Six minute walk distance , 6MWD ) quality life . Study design procedure : Patients receive information investigation , procedure carry risk , shall provide write consent consent form approve Cruces Hospital Ethics Clinical Trials Committee . Regarding outcome evaluation , patient , full intensity sham RMNMS , subject identical assessment functional procedure . Evaluation inclusion include clinical anamnesis physical exam , chest X-ray evaluation general blood exam biochemistry , include creatine kinase ( CK ) lactic dehydrogenase ( LD ) . In week start stimulation treatment 3 month hospital discharge , follow measurement carry : - Pulmonary function test - Health-related quality life , use SF3626 Saint George Respiratory Questionnaire ( SGRQ ) , self administer . - Body composition : fat-free mass ( FFM ) use bioelectric impedance method ( Bodystat-500 Bodystat Ltd , Douglas , UK ) express fat-free mass index ( FFMI ) , result FFM/ ( height ) 2 , height express meter . - Peripheral muscle function : Maximal voluntary contraction quadriceps ( MVCQ ) measure five maximum isometric contraction effort ( knee-extension attempt ) use Biopac dynamometer ( TSD 121C ) , Biopac system ( Biopac System , La Jolla CA , USA ) AcqKnowledge software . - Six-minute walking test ( 6MWT ) : carry 30 stretch , accord standard procedure . ( Am J Respir Crit Care Med 2002 ; 166:111e7 . ) A minimum three measurement shall carry initial assessment two post-protocol evaluation . RMNMS train protocol : training session start 7 10 day hospital discharge . Patients RMNMS group subject repetitive magnetic stimulation session 15 min thigh , alternatively two three day per week , period eight week . The assessment repeat three month hospital discharge . Stimulation : repetitive magnetic stimulation training quadriceps , RMNMS , provide MEDTRONIC Magpro MCF125 electromagnet refrigerate circular coil 60 mm radius , apply point upper third low two-thirds vastus lateralis , optimum location elicit contraction response , determine volunteer validation study . Patients sit recumbent position knee flexed 90º ankle fix strap . The intensity frequency stimulation adjust accord patient 's tolerance performance equipment . Stimulation follow cyclical pattern two second ON , contraction elicit burst twitch , four second OFF , repeat period 15 min thigh . With coil cool advance 5 ºC , possible maintain initial intensity 40 % equipment 's maximum stimulation capacity ( 2 T ) 15 Hz ( stimulus per second ) , end protocol intensity 70 % 7 Hz . Intensity increase 5 % every two session , condition patient report pain caused stimulation unpleasant sensation follow previous session . In case patient examine blood sample determine CK LD determination . Control group : patient receive sham train 20 % intensity schedule evaluation RMNMS patient . Identical RMNMS patient , assessment repeat three monts hospital discharge . Randomization Patients randomize either intervention group 1 , RNMMS sham train control group 2 . Scrambling code assignment perform patient assign , use stratification method consider four factor : age ≥ 65 vs. &lt; 65 year , previous admission yes / , ≥ 250 vs. walk test &lt; 250 meter FEV1 ≥ 50 vs. &lt; 50 % ; method aim obtain sufficient representation four parameter , control treatment group . Blinding ensure place stimulation coil effective simulated load patient blind outcome assessment conduct without reference membership specific group . Given complexity design , triple blind would unrealistic , therapist familiar assignment group . And also minimize difference assign group , monitor treatment record incident may exist process . Sample size The improvement distance walk 6 minute walk test regard main variable evaluate improvement discharge . An estimated population 32 patient , sixteen arm trial would enough show improvement 50 meter ( determine clinically relevant various study experience specialist ) , power 90 % ( beta ) possible significance 5 % ( alpha ) . Statistical analysis The nonparametric Mann Whitney test use comparison group , Wilcoxon 's test pair data use evaluate effect ( train control ) intervention within group . Comparison inter-group difference perform comparing percentage change per variable . Correlations variable analyse use Spearman 's nonparametric coefficient . Statistical significance : p &lt; 0.05 . The 95 % confidence interval ( CI ) also provide .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Clinical functional diagnosis COPD . Hospital admission COPD exacerbation respiratory department , ICU emergency department Hospital discharge . Cardiac pacemaker . Exacerbation major Heart disease pulmonary embolism . Lung cancer disseminate neoplasic disease . Severe renal hepatic disease . neurological disease , musculoskeletal cardiovascular treatment might interfere completion protocol assessment functional outcome .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>COPD</keyword>
	<keyword>Rehabilitation</keyword>
	<keyword>Neuromuscular stimulation</keyword>
	<keyword>Quadriceps muscle</keyword>
	<keyword>Magnetic stimulation</keyword>
</DOC>